📢 Your research deserves the spotlight – Submit your abstract by June 30, 2025!
Join us for the RNA Horizons 2025 Therapeutics Symposium, October 29-31, 2025 in Palermo, Sicily.
Join us for the RNA Horizons 2025 Therapeutics Symposium, October 29-31, 2025 in Palermo, Sicily. This premier event unites leading researchers to explore the latest RNA therapeutic advancements, from established modalities to emerging areas like ASOs and RNA structure-based therapies. Discussions will encompass key trends: pipeline diversification, enhanced RNA modalities, AI integration, and improved delivery technologies. Notably, the symposium will address translating discoveries into viable therapies, exploring commercialization and market access.
Connect with scientists, industry professionals, and investors to shape the future of RNA-based therapies.
This year’s symposium will delve into the following key research areas:
- RNA Approaches in Rare, Pulmonary & Neurodegenerative Diseases
- Delivery Technologies and High-Throughput Discovery
- Splicing Mechanisms as Therapeutic Targets
- RNA Binding Proteins and Translational Control in Cancer
- RNA-Based Regulation as a Strategy for Immunotherapy
- Targeting Noncoding and Regulatory RNA Elements
RNA Horizons Therapeutics 2025 Organizing Committee
Head of The Hadassah Cancer Research Institute (HCRI)
Hadassah Hebrew University Medical Center, Jerusalem, IL
Principal Investigator
Hebrew University-Hadassah Medical School, Jerusalem, IL, and University of Pennsylvania, USA
Ernesto Guccione
Principal Investigator, The Guccione Lab
Icahn School of Medicine at Mount Sinai, USA
Claudio Sette
Principal Investigator
Catholic University of the Sacred Heart, School of Medicine, Italy
Amalia Herszkowicz
Chief Operating Officer
Hadassah Cancer Research Institute, IL
Our events
ORGANIZERS
